Cancer Family
Precursor Lymphoid Neoplasm
CI-CAN-00000327Explore in graph →
Hematologic567 active trials12 approved drugs212 evidence items
- NCIt
- C7055
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000327Explore in graph →
Clinical trials
2,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (286)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04557436 | TT52CAR19 Therapy for B-cell Acute Lymphoblastic Leukaemia (B-ALL)(PBLTT52CAR19) | completed | Phase 1 | 9 | Great Ormond Street Hospital for Children NHS Foundation TrustOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT05845827 | Dietary Impact on Continuous Glucose Monitoring | completed | — | 30 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Feb 29, 2024 |
| clinicaltrials |
| NCT02168140 | CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma | completed | Phase 1 | 16 | Wake Forest University Health SciencesOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT02435849 | Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients(ELIANA) | completed | Phase 2 | 80 | Novartis PharmaceuticalsINDUSTRY | 11 | Feb 13, 2024 | clinicaltrials |
| NCT03964259 | Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia | completed | Phase 1 | 10 | Virginia Commonwealth UniversityOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT01802814 | International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010 | completed | Phase 3 | 700 | Charite University, Berlin, GermanyOTHER | 17 | Feb 9, 2024 | clinicaltrials |
| NCT01735955 | Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study | completed | Phase 4 | 57 | Novartis PharmaceuticalsINDUSTRY | 16 | Feb 8, 2024 | clinicaltrials |
| NCT04825548 | Post-thrombotic Syndrome After Deep Venous Thrombosis (DVT) in Patients Treated According to the NOPHO ALL2008 Protocol | completed | — | 27 | Aarhus University HospitalOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT04843150 | Pharmacokinetics and Immunogenicity of the First Doses of PEG-Asparaginase -An ALLTogether Pilot Study | completed | — | 320 | Aarhus University HospitalOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT04843514 | TDM of Asparaginase in ALL2008 | completed | — | 765 | Aarhus University HospitalOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT01041508 | Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia. | completed | Phase 1 | 18 | Therapeutic Advances in Childhood Leukemia ConsortiumOTHER | 1 | Feb 1, 2024 | clinicaltrials |
| NCT05560412 | Zein Nanoparticles for Glycemic Control(GLUCOCAPS) | completed | N/A | 69 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT05209360 | Heel Wedges and Carbon Fiber Custom Dynamic Orthoses to Control Knee Biomechanics(CDOKNEEpilot) | completed | N/A | 20 | University of IowaOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT04744818 | Effects of Iron Supplementation on Pediatric Vaccine Response(VINO) | completed | N/A | 288 | Jessica RiguttoOTHER | 2 | Jan 24, 2024 | clinicaltrials |
| NCT05973032 | MRD Detection by NGS in Pediatric B-ALL | completed | — | 430 | The Children's Hospital of Zhejiang University School of MedicineOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT05939791 | Physical Exercise and Dairy Probiotics in Childhood Cancer Survivors(Exerbioall) | completed | N/A | 29 | Comenius UniversityOTHER | 1 | Jan 16, 2024 | clinicaltrials |
| NCT01991457 | Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia(FluTBI) | completed | Phase 2 | 19 | University of Alabama at BirminghamOTHER | 1 | Jan 12, 2024 | clinicaltrials |
| NCT03833180 | A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001) | completed | Phase 1 | 91 | VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 1 | Jan 12, 2024 | clinicaltrials |
| NCT05045443 | Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia(CurcumPedALL) | completed | Phase 2 | 30 | Ain Shams UniversityOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT06195735 | Forecasting Hypersensitivity Against PEG-asparaginase to Optimize Outcome in ALL | completed | — | 649 | Aarhus University HospitalOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT04956666 | A Roll-over Study to Provide Continued Treatment With Lyophilized Pegaspargase (S95014) in Pediatric Patients With Acute Lymphoblastic Leukemia (ALL)(ALL) | completed | Phase 2 | 75 | Institut de Recherches Internationales ServierOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT05642988 | Application of Wearable Technology in High-risk Surgical Patients in the Perioperative Period | completed | — | 20 | Mater Misericordiae University HospitalOTHER | 1 | Dec 22, 2023 | clinicaltrials |
| NCT03919526 | Anti-CD19/CD22 Bispecific Chimeric Antigen Receptor（CAR)-T Cell Therapy for Measurable Residual Disease(MRD) Positive ALL | completed | Phase 1 | 19 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Dec 8, 2023 | clinicaltrials |
| NCT00697684 | Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant | completed | Phase 1 | 29 | Beth Israel Deaconess Medical CenterOTHER | 1 | Nov 28, 2023 | clinicaltrials |
| NCT04786275 | Evaluation of the Nociception Guided by NoL Index and PK of Fentanyl in Pediatric Patients Under General Anesthesia(NoLPedFenta) | completed | — | 25 | Pontificia Universidad Catolica de ChileOTHER | 1 | Nov 27, 2023 | clinicaltrials |
| NCT01523223 | Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies | completed | Phase 1 | 16 | Robert LowskyOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT03677596 | A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients | completed | Phase 4 | 102 | PfizerINDUSTRY | 8 | Nov 22, 2023 | clinicaltrials |
| NCT05059756 | PTNS and PFR in the Treatment of Childhood Constipation | completed | N/A | 84 | Shengjing HospitalOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT04145531 | An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) | completed | Phase 2 / Phase 3 | 229 | Jazz PharmaceuticalsINDUSTRY | 2 | Nov 18, 2023 | clinicaltrials |
| NCT02639559 | Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies | completed | Phase 2 | 50 | Washington University School of MedicineOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT00571662 | Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant | completed | Phase 2 | 76 | University of NebraskaOTHER | 1 | Oct 24, 2023 | clinicaltrials |
| NCT03916237 | Registry and Screening Tool to Identify Children With Asthma Likely to Benefit From Home Assessment and Remediation(CREST) | completed | N/A | 21 | MetroHealth Medical CenterOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT03096782 | Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma | completed | Phase 2 | 6 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT05665712 | Pediatric Enhanced Recovery After Cardiac Surgery(PERCS) | completed | — | 483 | University of AlbertaOTHER | 1 | Oct 5, 2023 | clinicaltrials |
| NCT01142427 | Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | completed | — | 17,463 | Children's Oncology GroupNETWORK | 7 | Oct 3, 2023 | clinicaltrials |
| NCT02767388 | Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery(Chemobrain) | completed | — | 45 | University of NebraskaOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT00003838 | Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow | completed | Phase 2 | 202 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Sep 21, 2023 | clinicaltrials |
| NCT02122081 | Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies | completed | Phase 1 | 33 | Sumithira VasuOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT02661035 | Allo HSCT Using RIC for Hematological Diseases | completed | Phase 2 | 156 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT05757882 | Reducing Fasting Time in Children for Sedation | completed | N/A | 100 | Eunah Cho, MDOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT02336282 | Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia | completed | N/A | 53 | St. Jude Children's Research HospitalOTHER | 1 | Sep 18, 2023 | clinicaltrials |
| NCT05498402 | Effect of IAM With an I-gel® on Ventilation Parameters in Simulated Pediatric OHCA | completed | N/A | 34 | Geneve TEAM AmbulancesOTHER | 1 | Sep 18, 2023 | clinicaltrials |
| NCT01696461 | A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor | completed | Phase 2 | 127 | Center for International Blood and Marrow Transplant ResearchNETWORK | 1 | Sep 14, 2023 | clinicaltrials |
| NCT06035614 | Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children | completed | N/A | 50 | ClarteisINDUSTRY | 1 | Sep 13, 2023 | clinicaltrials |
| NCT01951885 | Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention | completed | Phase 3 | 101 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT04224571 | CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children | completed | Phase 2 | 208 | Chinese University of Hong KongOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT04187248 | The Association Between Asparaginase Enzyme Activity Levels and Toxicities in Childhood Acute Lymphoblastic Leukaemia in NOPHOALL 2008 | completed | — | 1,248 | Aarhus University HospitalOTHER | 1 | Aug 25, 2023 | clinicaltrials |
| NCT01616238 | A Study for Older Adults With Acute Lymphoblastic Leukaemia(UKALL60+) | completed | Phase 2 | 126 | University College, LondonOTHER | 2 | Aug 16, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Mar 7, 2024source: clinicaltrials